Circular RNA-centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment

Junwu Wang1, Yu Tian2

  • 1Department of Thyroid and Breast Surgery, Chengdu Xinhua Hospital, Chengdu, China.

Gene
|May 30, 2026
PubMed

Insights

Circular RNAs (circRNAs) are key regulators in breast cancer, orchestrating complex networks that drive tumor progression and therapy resistance. Understanding these circRNA-centered networks offers new avenues for precision oncology.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly recognized as crucial regulatory molecules in breast cancer.
  • Their roles extend beyond microRNA sequestration to complex network organization.

Purpose of the Study:

  • To synthesize recent findings on circRNAs in breast cancer.
  • To propose a circRNA-centered network framework for understanding breast cancer biology.
  • To highlight the translational potential of circRNAs.

Main Methods:

  • Review of recent scientific literature on circRNAs in breast cancer.
  • Synthesis of data on circRNA functions including post-transcriptional control, RNA-protein interactions, translation, metabolism, and immune modulation.
  • Analysis of network-level convergence on signaling hubs.

Main Results:

  • CircRNAs act as central organizers of multilayered regulatory networks in breast cancer.
  • These networks integrate diverse biological processes, influencing tumor progression, invasion, immune escape, and therapy resistance.
  • CircRNAs converge on key signaling pathways like PI3K/AKT, YAP/TAZ, and STAT3, linking tumor plasticity to immune suppression.

Conclusions:

  • CircRNAs are central nodes in systems-level reprogramming of breast cancer.
  • CircRNA-centered networks provide a framework for understanding breast cancer complexity.
  • CircRNAs hold translational potential as biomarkers and therapeutic targets for precision oncology.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...